Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Comparison of ELISA and western blotting for human papillomavirus type 16 E7 antibody determination

A. Suchánková, L. Ritterová, M. Krčmář, V. Krchňák, J. Vágner, I. Jochmus, L. Gissmann, J. Kaňka, V. Vonka

. 1991 ; 72 (Pt 10) : 2577-2581.

Language English Country Great Britain

Document type Comparative Study

Persistent link   https://www.medvik.cz/link/bmc13030090

Grant support
IZ766 MZ0 CEP Register

A total of 140 sera originating from healthy women and women with either cervical intraepithelial neoplasia or cervical cancer were tested for the presence of IgG antibody against E7 of human papillomavirus type 16 (HPV-16) by ELISA using a synthetic icosapeptide, denoted 16/E7-2, representing amino acids 11 to 30, and by Western blotting (WB) using a genetically engineered HPV-16 E7 fusion protein. Eighteen sera were found positive in either one or the other test. Positive reactions were more frequently detected in cervical carcinoma patients (12 of 34, 35.2%) than in the other individuals (six of 106, 5.7%). Ten children's (1 to 3 years of age) sera reacted in neither ELISA nor WB with HPV-16 E7. A high degree of concordance between the two tests was found suggesting that both tests detect the same or similar activity. To locate the reacting epitopes in the E7 protein, absorption tests were performed with peptides corresponding to various sections of the protein. Based on the results obtained, sera possessing antibody to HPV-16 E7 could be differentiated into those reactive with only the 16/E7-2 peptide and those reactive with other HPV-16 E7 epitopes.

References provided by Crossref.org

Bibliography, etc.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc13030090
003      
CZ-PrNML
005      
20130920103712.0
007      
ta
008      
130919s1991 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1099/0022-1317-72-10-2577 $2 doi
035    __
$a (PubMed)1655964
040    __
$a ABA008 $d ABA008 $e AACR2 $b cze
041    0_
$a eng
044    __
$a xxk
100    1_
$a Suchánková, Alena $7 xx0104000 $u Department of Experimental Virology, Institute of Sera and Vaccines, Prague, Czechoslovakia
245    10
$a Comparison of ELISA and western blotting for human papillomavirus type 16 E7 antibody determination / $c A. Suchánková, L. Ritterová, M. Krčmář, V. Krchňák, J. Vágner, I. Jochmus, L. Gissmann, J. Kaňka, V. Vonka
504    __
$a Literatura
520    9_
$a A total of 140 sera originating from healthy women and women with either cervical intraepithelial neoplasia or cervical cancer were tested for the presence of IgG antibody against E7 of human papillomavirus type 16 (HPV-16) by ELISA using a synthetic icosapeptide, denoted 16/E7-2, representing amino acids 11 to 30, and by Western blotting (WB) using a genetically engineered HPV-16 E7 fusion protein. Eighteen sera were found positive in either one or the other test. Positive reactions were more frequently detected in cervical carcinoma patients (12 of 34, 35.2%) than in the other individuals (six of 106, 5.7%). Ten children's (1 to 3 years of age) sera reacted in neither ELISA nor WB with HPV-16 E7. A high degree of concordance between the two tests was found suggesting that both tests detect the same or similar activity. To locate the reacting epitopes in the E7 protein, absorption tests were performed with peptides corresponding to various sections of the protein. Based on the results obtained, sera possessing antibody to HPV-16 E7 could be differentiated into those reactive with only the 16/E7-2 peptide and those reactive with other HPV-16 E7 epitopes.
590    __
$a bohemika - dle Pubmed
650    02
$a dospělí $7 D000328
650    12
$a protilátky virové $x analýza $x imunologie $7 D000914
650    12
$a western blotting $7 D015153
650    12
$a ELISA $7 D004797
650    02
$a ženské pohlaví $7 D005260
650    02
$a lidé $7 D006801
650    02
$a lidé středního věku $7 D008875
650    12
$a onkogenní proteiny virové $x imunologie $7 D009856
650    12
$a Papillomaviridae $x imunologie $7 D027383
650    02
$a Papillomavirus E7 - proteiny $7 D050725
650    02
$a nádory děložního čípku $x mikrobiologie $7 D002583
655    _2
$a srovnávací studie $7 D003160
700    1_
$a Ritterová, L. $u Department of Experimental Virology, Institute of Sera and Vaccines, Prague, Czechoslovakia $7 _AN074762
700    1_
$a Krčmář, M. $u Department of Experimental Virology, Institute of Sera and Vaccines, Prague, Czechoslovakia $7 _AN074763
700    1_
$a Krchňák, Viktor $7 _AN073592 $u Department of Synthetic Peptides, Institute of Sera and Vaccines, Prague, Czechoslovakia
700    1_
$a Vágner, J. $7 _AN074765 $u Department of Synthetic Peptides, Institute of Sera and Vaccines, Prague, Czechoslovakia
700    1_
$a Jochmus, I. $u Deutsches Krebsforschungszentrum, Heidelberg, Germany
700    1_
$a Gissmann, L. $u Deutsches Krebsforschungszentrum, Heidelberg, Germany
700    1_
$a Kaňka, Jiří, $d 1925-2005 $7 jk01052861 $u Department of Obstetrics and Gynaecology, Third Medical Faculty, Charles University, Prague, Czechoslovakia
700    1_
$a Vonka, Vladimír, $d 1930- $7 jk01150642 $u Department of Experimental Virology, Institute of Sera and Vaccines, Prague, Czechoslovakia
773    0_
$t Journal of General Virology $x 0022-1317 $g Roč. 72, č. Pt 10 (1991), s. 2577-2581 $p J Gen Virol $w MED00002692
773    0_
$p J Gen Virol $g 72 ( Pt 10):2577-81, 1991 Oct $x 0022-1317
910    __
$a ABA008 $b B 1317 $y 3 $z 0
990    __
$a 20130919085602 $b ABA008
991    __
$a 20130920104220 $b ABA008
999    __
$a ok $b bmc $g 994139 $s 828532
BAS    __
$a 3
BMC    __
$a 1991 $b 72 $c Pt 10 $d 2577-2581 $i 0022-1317 $m Journal of general virology $x MED00002692 $n J Gen Virol
GRA    __
$a IZ766 $p MZ0
LZP    __
$a 2013-09/vlbo

Find record

Citation metrics

Archiving options